Are there different rates of osteonecrosis of the jaw between different bisphosphonates?
Abstract
Different bisphosphonates are associated with varied rates of osteonecrosis of the jaw, with Zoledronic acid showing higher rates of ONJ, especially in cancer patients, compared to oral options or within osteoporosis therapy contexts.
Fields of Study & Subjects
Bone health and treatments
Oral health in cancer treatment
Bone health and osteoporosis research
Publication details
- Journal / source
- Zenodo (CERN European Organization for Nuclear Research)
- Publication date
- 29 January 2026
- Language
- EN